Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Belani

Showing results (21-30 of 298) with videos related to

Pageof 30
Sort By:
Seminars in Oncology|August 15, 1998
Single agents in the second-line treatment of non-small cell lung cancerC P Belani
Seminars in Oncology|February 24, 2005
Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myelomaChandra P Belani
Lung Cancer (Amsterdam, Netherlands)|March 25, 2006
Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxelChandra P Belani
Clinical Lung Cancer|June 10, 2005
The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancerChandra P Belani
Clinical Lung Cancer|December 6, 2003
Individualized therapy for non-small cell lung cancerC P Belani
Clinical Lung Cancer|December 12, 2003
Clinical lung cancer indexed in Index Medicus and MedlineChandra P Belani
Clinical Lung Cancer|January 7, 2004
Creating a molecular classification for lung cancerChandra P Belani
Clinical Lung Cancer|November 20, 2003
Adjuvant therapy for surgically resected non-small-cell lung cancer: will it become a reality?Chandra P Belani
Clinical Lung Cancer|January 17, 2004
Docetaxel in combination with platinum compounds for non small-cell lung cancerC P Belani
Clinical Lung Cancer|January 21, 2004
Locally advanced, unresectable non-small cell lung cancer shift in the treatment paradigmC P Belani
Pageof 30

Showing results (21-30 of 298) with videos related to

Sort By:
Pageof 30
Seminars in Oncology|August 15, 1998
Single agents in the second-line treatment of non-small cell lung cancerC P Belani
Seminars in Oncology|February 24, 2005
Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myelomaChandra P Belani
Lung Cancer (Amsterdam, Netherlands)|March 25, 2006
Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxelChandra P Belani
Clinical Lung Cancer|June 10, 2005
The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancerChandra P Belani
Clinical Lung Cancer|December 6, 2003
Individualized therapy for non-small cell lung cancerC P Belani
Clinical Lung Cancer|December 12, 2003
Clinical lung cancer indexed in Index Medicus and MedlineChandra P Belani
Clinical Lung Cancer|January 7, 2004
Creating a molecular classification for lung cancerChandra P Belani
Clinical Lung Cancer|November 20, 2003
Adjuvant therapy for surgically resected non-small-cell lung cancer: will it become a reality?Chandra P Belani
Clinical Lung Cancer|January 17, 2004
Docetaxel in combination with platinum compounds for non small-cell lung cancerC P Belani
Clinical Lung Cancer|January 21, 2004
Locally advanced, unresectable non-small cell lung cancer shift in the treatment paradigmC P Belani
Pageof 30